Market Tracker

01/18 5:10pm ET

AstraZeneca PLC (NYSE:AZN)

28.50
Delayed Data
As of 4:02pm ET
 +0.03 / +0.11%
Today’s Change
25.55
Today|||52-Week Range
35.04
+4.32%
Year-to-Date
AstraZeneca Offers Update on Immuno-Oncology Program
9:30am / Zacks.com - Paid Partner Content
Can AstraZeneca (AZN) Be a Solid Choice for Value Investors?
Jan 10 / Zacks.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Thursday
Jan 12 / TheStreet.com - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
European Pharma Shares Hammered After Trump Press Conference Attack
Jan 12 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 V...
Jan 06 / Zacks.com - Paid Partner Content
Bristol-Myers and AstraZeneca Take Beatings
Jan 11 / TheStreet.com - Paid Partner Content
Trump threat fails to halt drug price hikes in 2017
Jan 04 / CNNMoney.com

Today’s Trading

Previous close28.47
Today’s open28.65
Day’s range28.43 - 28.66
Volume6,141,814
Average volume (3 months)6,717,934
Market cap$72.0B
Dividend yield4.91%
Data as of 4:02pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-1.09%
Earnings growth (next 5 years)+1.28%
Revenue growth (last year)-5.11%
P/E ratio29.4
Price/Sales3.48
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.16-0.44%
ABTAbbott Laboratories-0.14-0.34%
AGNAllergan+1.78+0.83%
LLYEli Lilly and Co+0.68+0.88%
Data as of 4:02pm ET, 01/18/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.59
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts